New Risk • Jun 12
New major risk - Market cap size The company's market capitalization is less than US$100m. Market cap: RM39.7m (US$9.78m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-RM3.5m free cash flow). Earnings have declined by 40% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (9.5% average weekly change). Market cap is less than US$100m (RM39.7m market cap, or US$9.78m). New Risk • May 31
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -RM2.1m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-RM2.1m free cash flow). Earnings have declined by 40% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Market cap is less than US$100m (RM42.8m market cap, or US$10.8m). Announcement • Apr 29
Adventa Berhad, Annual General Meeting, Jun 23, 2026 Adventa Berhad, Annual General Meeting, Jun 23, 2026, at 15:00 Singapore Standard Time. Location: 21, jalan tandang 51/205a, seksyen 51, 46050 petaling jaya, selangor darul ehsan, Malaysia New Risk • Mar 31
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Malaysian stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 39% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.2% average weekly change). Market cap is less than US$100m (RM45.8m market cap, or US$11.3m). New Risk • Mar 09
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: RM38.2m (US$9.62m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 39% per year over the past 5 years. Market cap is less than US$10m (RM38.2m market cap, or US$9.62m). New Risk • Mar 02
New major risk - Revenue and earnings growth Earnings have declined by 39% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 39% per year over the past 5 years. Minor Risk Market cap is less than US$100m (RM44.3m market cap, or US$11.3m). Reported Earnings • Mar 02
Full year 2025 earnings released: RM0.018 loss per share (vs RM0.007 profit in FY 2024) Full year 2025 results: RM0.018 loss per share (down from RM0.007 profit in FY 2024). Revenue: RM53.3m (down 8.6% from FY 2024). Net loss: RM5.46m (down 349% from profit in FY 2024). Over the last 3 years on average, earnings per share has increased by 76% per year but the company’s share price has fallen by 36% per year, which means it is significantly lagging earnings. Reported Earnings • Nov 26
Third quarter 2025 earnings released: EPS: RM0.001 (vs RM0.002 in 3Q 2024) Third quarter 2025 results: EPS: RM0.001 (down from RM0.002 in 3Q 2024). Revenue: RM11.8m (down 24% from 3Q 2024). Net income: RM172.0k (down 74% from 3Q 2024). Profit margin: 1.5% (down from 4.3% in 3Q 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 69% per year but the company’s share price has fallen by 36% per year, which means it is significantly lagging earnings. Reported Earnings • Aug 28
Second quarter 2025 earnings released: EPS: RM0.001 (vs RM0.001 in 2Q 2024) Second quarter 2025 results: EPS: RM0.001 (in line with 2Q 2024). Revenue: RM13.9m (up 13% from 2Q 2024). Net income: RM438.0k (up 28% from 2Q 2024). Profit margin: 3.1% (up from 2.8% in 2Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has fallen by 33% per year, which means it is significantly lagging earnings. New Risk • Jul 08
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Malaysian stocks, typically moving 9.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (9.0% average weekly change). Market cap is less than US$100m (RM61.1m market cap, or US$14.4m). Reported Earnings • May 21
First quarter 2025 earnings released: EPS: RM0.001 (vs RM0.001 in 1Q 2024) First quarter 2025 results: EPS: RM0.001 (in line with 1Q 2024). Revenue: RM13.6m (flat on 1Q 2024). Net income: RM313.0k (up 3.0% from 1Q 2024). Profit margin: 2.3% (in line with 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has fallen by 36% per year, which means it is performing significantly worse than earnings. Announcement • Apr 29
Adventa Berhad, Annual General Meeting, Jun 23, 2025 Adventa Berhad, Annual General Meeting, Jun 23, 2025, at 15:00 Singapore Standard Time. Location: 21, jalan tandang 51/205a,, seksyen 51, 46050 petaling jaya, selangor darul ehsan, Malaysia Reported Earnings • Mar 02
Full year 2024 earnings released: EPS: RM0.007 (vs RM0.054 loss in FY 2023) Full year 2024 results: EPS: RM0.007 (up from RM0.054 loss in FY 2023). Revenue: RM58.3m (up 56% from FY 2023). Net income: RM2.10m (up RM11.2m from FY 2023). Profit margin: 3.6% (up from net loss in FY 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 54% per year but the company’s share price has only fallen by 33% per year, which means it has not declined as severely as earnings. New Risk • Dec 06
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Malaysian stocks, typically moving 7.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-RM16m free cash flow). Minor Risks Share price has been volatile over the past 3 months (7.2% average weekly change). Market cap is less than US$100m (RM96.3m market cap, or US$21.8m). Reported Earnings • Nov 30
Third quarter 2024 earnings released: EPS: RM0.002 (vs RM0.013 loss in 3Q 2023) Third quarter 2024 results: EPS: RM0.002 (up from RM0.013 loss in 3Q 2023). Revenue: RM15.4m (up 90% from 3Q 2023). Net income: RM663.0k (up RM2.60m from 3Q 2023). Profit margin: 4.3% (up from net loss in 3Q 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 50 percentage points per year, which is a significant difference in performance. Reported Earnings • Aug 27
Second quarter 2024 earnings released: EPS: RM0.001 (vs RM0.017 loss in 2Q 2023) Second quarter 2024 results: EPS: RM0.001 (up from RM0.017 loss in 2Q 2023). Revenue: RM12.3m (up 85% from 2Q 2023). Net income: RM342.0k (up RM2.88m from 2Q 2023). Profit margin: 2.8% (up from net loss in 2Q 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 58 percentage points per year, which is a significant difference in performance. Reported Earnings • May 04
First quarter 2024 earnings released: EPS: RM0.001 (vs RM0.005 loss in 1Q 2023) First quarter 2024 results: EPS: RM0.001 (up from RM0.005 loss in 1Q 2023). Revenue: RM13.5m (down 1.8% from 1Q 2023). Net income: RM304.0k (up RM1.13m from 1Q 2023). Profit margin: 2.3% (up from net loss in 1Q 2023). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 51 percentage points per year, which is a significant difference in performance. Announcement • May 01
Adventa Berhad, Annual General Meeting, Jun 21, 2024 Adventa Berhad, Annual General Meeting, Jun 21, 2024, at 15:00 Singapore Standard Time. Location: Jalan Tandang 51/205A, Seksyen 51, 46050 Petaling Jaya Selangor Darul Ehsan Malaysia Agenda: To receive the Audited Financial Statements for the financial year ended 31December 2023 together with the Reports of the Directors and the Auditors thereon; to approve the payment of Directors' fees and benefits amounting to RM336,000/- for the financial year ending 31 December 2024; to re-elect Encik Muhamad Yazdi bin Che Ya who retire pursuant to Clause 113 of the Company's Constitution and being eligible, has offered himself for re-election; o re-elect the Directors who retire pursuant to Clause 114 of the Company's Constitution and being eligible, have offered themselves for re-election; and to discuss other mattes. Reported Earnings • Feb 28
Full year 2023 earnings released: RM0.029 loss per share (vs RM0.034 loss in FY 2022) Full year 2023 results: RM0.029 loss per share. Revenue: RM37.2m (down 37% from FY 2022). Net loss: RM8.76m (loss widened 70% from FY 2022). New Risk • Nov 30
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Malaysian stocks, typically moving 10% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10% average weekly change). Shareholders have been substantially diluted in the past year (100% increase in shares outstanding). Minor Risk Market cap is less than US$100m (RM91.7m market cap, or US$19.6m). Reported Earnings • Nov 29
Third quarter 2023 earnings released: RM0.013 loss per share (vs RM0.013 loss in 3Q 2022) Third quarter 2023 results: RM0.013 loss per share (in line with 3Q 2022). Revenue: RM8.12m (down 21% from 3Q 2022). Net loss: RM1.94m (loss widened 1.4% from 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has fallen by 45% per year, which means it is performing significantly worse than earnings. New Risk • Nov 23
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 100% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (100% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (10.0% average weekly change). Market cap is less than US$100m (RM94.7m market cap, or US$20.2m). Announcement • Nov 11
Adventa Berhad Announces the Resignation of Datuk Mark Victor Rozario as Chief Executive Officer Adventa Berhad announced the resignation of Datuk Mark Victor Rozario as Chief Executive Officer. Date of change is 15 November 2023. Age is 59. To focus on personal commitments. New Risk • Oct 27
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Malaysian stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.9% average weekly change). Market cap is less than US$100m (RM55.0m market cap, or US$11.5m). New Risk • Oct 20
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: RM45.8m (US$9.61m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. This is currently the only risk that has been identified for the company. Reported Earnings • Aug 30
Second quarter 2023 earnings released: RM0.017 loss per share (vs RM0.001 profit in 2Q 2022) Second quarter 2023 results: RM0.017 loss per share (down from RM0.001 profit in 2Q 2022). Revenue: RM6.66m (down 70% from 2Q 2022). Net loss: RM2.54m (down RM2.62m from profit in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 44% per year, which means it is significantly lagging earnings. Reported Earnings • May 19
First quarter 2023 earnings released: RM0.005 loss per share (vs RM0.005 profit in 1Q 2022) First quarter 2023 results: RM0.005 loss per share (down from RM0.005 profit in 1Q 2022). Revenue: RM13.8m (down 25% from 1Q 2022). Net loss: RM825.0k (down 218% from profit in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has fallen by 18% per year, which means it is significantly lagging earnings. Buying Opportunity • Mar 14
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 16%. The fair value is estimated to be RM0.65, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 22% over the last 3 years. Meanwhile, the company became loss making. Reported Earnings • Feb 26
Full year 2022 earnings released: RM0.033 loss per share (vs RM0.052 profit in FY 2021) Full year 2022 results: RM0.033 loss per share (down from RM0.052 profit in FY 2021). Revenue: RM58.9m (down 40% from FY 2021). Net loss: RM4.98m (down 163% from profit in FY 2021). Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Reported Earnings • Dec 04
Third quarter 2022 earnings released: RM0.013 loss per share (vs RM0.017 profit in 3Q 2021) Third quarter 2022 results: RM0.013 loss per share (down from RM0.017 profit in 3Q 2021). Revenue: RM10.3m (down 76% from 3Q 2021). Net loss: RM1.92m (down 176% from profit in 3Q 2021). Over the last 3 years on average, earnings per share has increased by 79% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth. Reported Earnings • Aug 31
Second quarter 2022 earnings released: EPS: RM0.001 (vs RM0.05 in 2Q 2021) Second quarter 2022 results: EPS: RM0.001 (down from RM0.05 in 2Q 2021). Revenue: RM21.9m (up 9.2% from 2Q 2021). Net income: RM82.0k (down 99% from 2Q 2021). Profit margin: 0.4% (down from 38% in 2Q 2021). The decrease in margin was driven by higher expenses. Reported Earnings • May 30
First quarter 2022 earnings: EPS and revenues miss analyst expectations First quarter 2022 results: EPS: RM0.005 (up from RM0.007 loss in 1Q 2021). Revenue: RM18.3m (up 41% from 1Q 2021). Net income: RM700.0k (up RM1.82m from 1Q 2021). Profit margin: 3.8% (up from net loss in 1Q 2021). The move to profitability was driven by higher revenue. Revenue missed analyst estimates by 2.1%. Earnings per share (EPS) also missed analyst estimates by 78%. Announcement • May 18
Adventa Berhad, Annual General Meeting, Jun 23, 2022 Adventa Berhad, Annual General Meeting, Jun 23, 2022, at 10:30 China Standard Time. Agenda: To consider approval for the Proposed Renewal of RRPT Mandate; and to consider other matters. Reported Earnings • Feb 25
Full year 2021 earnings: EPS and revenues miss analyst expectations Full year 2021 results: EPS: RM0.084 (up from RM0.077 loss in FY 2020). Revenue: RM99.1m (up 14% from FY 2020). Net income: RM12.8m (up RM24.6m from FY 2020). Profit margin: 13% (up from net loss in FY 2020). The move to profitability was primarily driven by higher revenue. Revenue missed analyst estimates by 2.1%. Earnings per share (EPS) also missed analyst estimates by 78%. Over the last 3 years on average, earnings per share has increased by 64% per year but the company’s share price has only increased by 31% per year, which means it is significantly lagging earnings growth. Reported Earnings • Nov 25
Third quarter 2021 earnings: EPS and revenues miss analyst expectations Third quarter 2021 results: EPS: RM0.017 (up from RM0.034 loss in 3Q 2020). Revenue: RM43.4m (up 200% from 3Q 2020). Net income: RM2.53m (up RM7.69m from 3Q 2020). Profit margin: 5.8% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Revenue missed analyst estimates by 2.1%. Earnings per share (EPS) also missed analyst estimates by 78%. Earnings per share (EPS) missed analyst estimates by 78%. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has increased by 38% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Aug 26
Second quarter 2021 earnings released: EPS RM0.051 (vs RM0.011 in 2Q 2020) The company reported a decent second quarter result with improved earnings and profit margins, although revenues were weaker. Second quarter 2021 results: Revenue: RM20.1m (down 57% from 2Q 2020). Net income: RM7.71m (up 356% from 2Q 2020). Profit margin: 38% (up from 3.6% in 2Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has increased by 50% per year, which means it is well ahead of earnings. Reported Earnings • May 30
First quarter 2021 earnings released: RM0.007 loss per share (vs RM0.007 profit in 1Q 2020) The company reported a poor first quarter result with weaker earnings, revenues and control over costs. First quarter 2021 results: Revenue: RM13.0m (down 5.3% from 1Q 2020). Net loss: RM1.12m (down 211% from profit in 1Q 2020). Over the last 3 years on average, earnings per share has fallen by 35% per year but the company’s share price has increased by 58% per year, which means it is well ahead of earnings. Announcement • May 05
Low Chin Guan completed the acquisition of Lucenxia (M) Sdn. Bhd from Adventa Berhad (KLSE:ADVENTA). Low Chin Guan agreed to acquire Lucenxia (M) Sdn. Bhd from Adventa Berhad (KLSE:ADVENTA) for MYR 11 million on February 5, 2021. The consideration is to be paid in full by Low in cash on a date within 30 days from the date on which all conditions are satisfied. Luxcenxia reported a revenue of MYR 49.5 million. The transaction is subject to approval of shareholders of Adventa at an EGM to be convened and approval of other relevant parties within a period of 90 days from the date of share sale agreement. As of May 3, 2021, all the conditions precedent to the transaction have been fulfiulled. If any of the condition is not fulfilled or waived within a period of 90 days the SSA may be terminated or delayed. The proposed acquisition is expected to be completed in the second quarter of 2021. Post completion Adventa and its subsidiaries shall be forbidden to use the name "Luxcenxia" and other brands currently used by Lucenxia.
Low Chin Guan completed the acquisition of Lucenxia (M) Sdn. Bhd from Adventa Berhad (KLSE:ADVENTA) on May 3, 2021. Is New 90 Day High Low • Mar 01
New 90-day low: RM1.05 The company is down 44% from its price of RM1.88 on 01 December 2020. The Malaysian market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is down 32% over the same period. Reported Earnings • Feb 27
Full year 2020 earnings released: RM0.077 loss per share (vs RM0.08 loss in FY 2019) The company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2020 results: Revenue: RM87.2m (up 189% from FY 2019). Net loss: RM11.7m (loss narrowed 4.2% from FY 2019). Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has increased by 26% per year, which means it is well ahead of earnings. Is New 90 Day High Low • Feb 05
New 90-day low: RM1.47 The company is down 42% from its price of RM2.54 on 06 November 2020. The Malaysian market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is down 27% over the same period. Is New 90 Day High Low • Dec 29
New 90-day low: RM1.53 The company is down 29% from its price of RM2.16 on 30 September 2020. The Malaysian market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is down 27% over the same period. Is New 90 Day High Low • Dec 07
New 90-day low: RM1.56 The company is down 24% from its price of RM2.05 on 08 September 2020. The Malaysian market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is down 10.0% over the same period. Reported Earnings • Nov 26
Third quarter 2020 earnings released: RM0.034 loss per share The company reported a solid third quarter result with reduced losses and improved revenues and control over expenses. Third quarter 2020 results: Revenue: RM14.5m (up 24% from 3Q 2019). Net loss: RM5.16m (loss narrowed 20% from 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has increased by 49% per year, which means it is well ahead of earnings. 
